Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06098482 · ClinicalTrials.gov registry record · NA
An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App
A NA study of Hearing Loss, sponsored by Cochlear.
- Recruiting
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 4
- Study locations
NCT06098482: Recruiting NA study of Hearing Loss, sponsored by Cochlear.
NCT06098482 is a NA study of Hearing Loss that is actively recruiting participants, run by Cochlear. The registered enrollment target is 46 participants, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06098482, a NA study of Hearing Loss, is actively recruiting participants, sponsored by Cochlear.
- RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 4
- Study locations
Study Summary
The study is a feasibility, prospective, repeated-measures, multi-country, multi-centre, study of the Mobile Research App to measure and validate speech perception endpoints in adult cochlear implant recipients.
Primary Outcome
To determine if test-retest reliability with a correlation greater than or equal to 0.8 can be achieved for speech perception ability measured on the MRA outside the sound booth, percent correct performance for the test and retest runs of the speech perception ability will be compared. Scoring: Percentage correct Range: 0-100%, higher scores equal better performance
Conditions Studied
Interventions
- DEVICE Mobile Research App (MRA)
- OTHER SOC/validated delivery of the speech perception test material
Study Locations (4)
Antwerp
- European Institute for Otorhinolaryngology (EIORL) ENT department Sint-Augustinus Antwerp - Antwerp
- Hoorzorg van Looveren - Wommelgem
Colorado
- Denver Research and Technology Labs - Lone Tree
Victoria
- HEARnet Clinical Studies - Melbourne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2027-05-02 |
| Phase | NA |
What NCT06098482 shows while recruiting
NCT06098482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Mobile Research App (MRA) is the first listed.
NCT06098482 reports a single indexed study location in Antwerp, Colorado, Victoria.
Frequently Asked Questions
What is clinical trial NCT06098482 about?
NCT06098482 is a clinical study titled "An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App". The study is a feasibility, prospective, repeated-measures, multi-country, multi-centre, study of the Mobile Research App to measure and validate speech perception endpoints in adult cochlear implant recipients.
What is the current status of trial NCT06098482?
This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2024-02-05. Estimated completion is 2027-05-02.
What conditions does trial NCT06098482 study?
This clinical trial studies the following conditions: Hearing Loss.
What interventions are being tested in trial NCT06098482?
The interventions under investigation include: Mobile Research App (MRA) (DEVICE), SOC/validated delivery of the speech perception test material (OTHER).
Who is sponsoring clinical trial NCT06098482?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06098482 being conducted?
This trial has 4 study locations across Colorado, Victoria, Antwerp. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06098482's enrollment target sits among peer trials
46 42nd of 58 higher than 17 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI